Orthofix Announces 510(k) Clearance and First Implant of Fitbone Transport and Lengthening System

Published on July 9, 2024

LEWISVILLE, Texas, July 9, 2024–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the 510(k) clearance and first U.S. implant of the Fitbone™ Transport and Lengthening System. Used to treat large bone defects in the femur and tibia due to trauma, infectious or malignant conditions, the device is the only intramedullary …

The post Orthofix Announces 510(k) Clearance and First Implant of Fitbone Transport and Lengthening System appeared first on Ortho Spine News.

Continue reading on website
Other news

Strengthened presence in Europe

July 8, 2024
Spineway continues its sales and marketing efforts in Europe Press release – Ecully, July 8, 2024 – The Spineway Group, a specialist in innovative implants for the treatment of severe spine disorders, announces that it participated in the 38th edition of GEER, the annual congress of the Spanish Spine Society, held in Malaga in May. GEER is …The post Strengthened presence in Europe appeared first o

Mainstay Medical Announces Receipt of European and Australian Approvals of MRI Labeling on ReActiv8® Restorative Neurostimulation System™

July 9, 2024
MRI clearances received in connection with certification of conformity with EU and UK Medical Device Regulations DUBLIN, July 9, 2024–(BUSINESS WIRE)–Mainstay Medical Holdings plc today announced that it has received regulatory approvals in the European Union, the United Kingdom and Australia for full-body MR conditional labeling for the ReActiv8® Restorative Neurostimulation system. As a result,